Unknown

Dataset Information

0

Catheter ablation for atrial fibrillation in a low-volume center using contemporary technology.


ABSTRACT: Background:Catheter ablation is increasingly being performed worldwide for atrial fibrillation (AF). However, there are concerns of lower success rates and higher complications of AF ablations performed in low-volume centers. Thus, we sought to evaluate the safety and efficacy of AF catheter ablation in a low-volume center using contemporary technologies. Methods and results:71 consecutive patients (50 paroxysmal AF [pAF] vs 21 persistent AF) who underwent first catheter ablation were studied. Primary outcome was AF recurrence rate. Secondary outcomes included periprocedural complications, hospitalization for symptomatic tachy-arrhythmias post-ablation and number of repeat ablations. Mean age of our cohort was 59.1 ± 9.7 years, of which 56 (78.9%) were males. 1-year AF recurrence was 19.5% in pAF and 23.8% in persistent AF (p = 0.694). Ablation in persistent AF group required longer procedural (197.76 ± 48.60 min [pAF] vs 238.67 ± 70.50 min [persistent AF], p = 0.006) and ablation duration (35.08 ± 15.84 min [pAF] vs 52.65 ± 28.46 min [persistent AF], p = 0.001). There were no significant differences in secondary outcomes. Major periprocedural complication rate was 2.8%.Subset analysis on (i) cryoablation vs radiofrequency, (ii) Ensite vs CARTO navigational system and (iii) circular vs high density mapping catheter did not yield significant differences in primary or secondary outcomes. Conclusions:The AF ablation complication and recurrence free rates in both paroxysmal and persistent AF at one year were comparable to high-volume centers. Long-term follow up is needed. In addition, first AF catheter ablation in a low-volume center is realistic with comparable efficacy and safety outcomes to high-volume centers using contemporary ablation technologies.

SUBMITTER: Tay JCK 

PROVIDER: S-EPMC7591346 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC4229444 | BioStudies
1000-01-01 | S-EPMC4090097 | BioStudies
| S-EPMC6842421 | BioStudies
2019-01-01 | S-EPMC6706423 | BioStudies
2016-01-01 | S-EPMC5052470 | BioStudies
2016-01-01 | S-EPMC5121491 | BioStudies
2020-01-01 | S-EPMC7036070 | BioStudies
2015-01-01 | S-EPMC4493108 | BioStudies
2020-01-01 | S-EPMC7536288 | BioStudies
2016-01-01 | S-EPMC4880114 | BioStudies